﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Medical Journal of Tabriz University of Medical Sciences</JournalTitle>
      <Issn>2783-2031</Issn>
      <Volume>30</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2008</Year>
        <Month>06</Month>
        <DAY>23</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>The Effects of Enalapril and Losartan on DNA Damage in Renal Transplant Recipients with Regarding to Renin-Angiotensin System Polymorphisms</ArticleTitle>
    <FirstPage>133</FirstPage>
    <LastPage>140</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>
        </FirstName>
        <LastName>VEISI P</LastName>
      </Author>
      <Author>
        <FirstName>
        </FirstName>
        <LastName>GHORBANIHAGHJO A</LastName>
      </Author>
      <Author>
        <FirstName>
        </FirstName>
        <LastName>ARGANI H</LastName>
      </Author>
      <Author>
        <FirstName>
        </FirstName>
        <LastName>AGHAEISHAHSAVARI M</LastName>
      </Author>
      <Author>
        <FirstName>
        </FirstName>
        <LastName>NOROOZIANAVVAL M</LastName>
      </Author>
      <Author>
        <FirstName>
        </FirstName>
        <LastName>RASHTCHIZADEH N</LastName>
      </Author>
      <Author>
        <FirstName>
        </FirstName>
        <LastName>SAFA J</LastName>
      </Author>
      <Author>
        <FirstName>
        </FirstName>
        <LastName>MESGARI M</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">
      </ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2009</Year>
        <Month>12</Month>
        <Day>03</Day>
      </PubDate>
    </History>
    <Abstract>Background and Objectives: Oxidative injury of DNA and lipids may be supervised by renin-angiotensin system (RAS). In the study the effect of losartan (L) and/or enalapril (E) on reduction of DNA damage was evaluated regarding to renin-angiotensin system polymorphisms. Materials and Methods: After determination of genotypes of the angiotensin converting enzyme (ACE I/D), angiotensinogen (AGT M235T) and angiotensin II type 1 receptor (ATR1 A1166C) by polymerase chain reaction, 64 renal transplant recipients randomly allocated to one of the four groups: first (13 patients) and second (20 patients) groups were treated with E (E+: 10mg/d) and L (L+: 50 mg/d) alone respectively. The third group (13 patients) as positive control received E+L (E+L+: 10mg/d + 50 mg/d) and the forth group (22 cases) received no medication as negative control (E-L-). The subjects were followed for 8 weeks. After 2 weeks washout period, E group changed to L and vice versa as cross-over design. They were followed for another 8 weeks. Before and after 2 months treatment, we checked the serum 8-OHdG and Malondialdehyde (MDA) as biomarkers of DNA damage and lipid peroxidation respectively. Results: Serum 8-OHdG levels were significantly decreased in the E+L+ and L+ groups (6.07±1.1 ng/ml to 3.6±0.58 ng/ml, P=0.000; 5.30±0.86 ng/ml to 3.6±0.47 ng/ml, P=0.001 respectively). 8-OHdG level was not decreased significantly in E+ group (6±1.19 ng/ml to 4.7±1.39 ng/ml, P=0.07) and E-L- group (5.30±0.84 to 5.6±0.88 ng/ml, P=0.11). Patients with DD genotype of ACE and CC genotype of ATR1 had higher serum 8-OHdG levels at the baseline (P=0.02, P=0.002 respectively). Only TT genotype of AGT had the most ant oxidative role regarding to kind of above treatment regimens (P=0.01). We found a remarkable correlation between MDA and DNA damage levels before and after intervention (r=0.48, P=0.000; r=0.35, P=0.006). Conclusion: Although serum 8-OHdG level is higher in DD and CC genotypes of ACE and ATR1 polymorphisms; the protective effects of L+ and E+L+ on DNA breaks are surprising regarding to the RAS genotypes. TT genotype of AGT had important role in prevention of DNA break regarding to kind of treatment.</Abstract>
  </Article>
</ArticleSet>